Equites Radar

USPH · U.S. Physical Therapy, Inc.

Medical Care FacilitiesUnited StatesAnalyst view: Buy

$78.43

+0.93% last session

End-of-day data · close of 2026-09-11

Mildly bullish3 bullish · 1 bearish technical signals
Consensus: Buy (1.86 from 6 analysts)
To mean target: +22.2%

Market cap

$1B

Enterprise value

$2B

Trailing P/E

457.1

Forward P/E

23.0

Dividend yield

2.0%

Beta

1.12

Avg volume

0M

Employees

5K

Daily Change %

0.93%

5 Days Change

-1.87%

10 Days Change

0.17%

30 Days Change

-4.09%

60 Days Change

7.98%

Month to Day Change

0.15%

Year to Day Change

1.65%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.86
Covering analysts6
Mean price target$95.00
Low price target$88.00
Upside to mean target+22.2%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)53.0
50-day MA$76.58
200-day MA$74.78
Price vs 50-day MA+2.4%
Price vs 200-day MA+4.9%
MACD histogram-0.24
Volume vs 3-month avg0.5×
52w low $58.2252w high $90.82

Analyst sentiment over time — USPH

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-09-11

Latest call per bank · past 12 months

JP Morgan

Overweight

$95.00

+22.2% vs price
▲ raised from $90.00Maintains · 2026-09-11

Recent rating actions

DateFirmActionRatingPrice target
2026-09-11JP MorganMaintainsOverweight$90.00 $95.00
2026-08-10Barrington ResearchMaintainsOutperform$90.00 $98.00
2026-06-24CitizensReiteratesMarket Outperform$98.00
2026-05-13Barrington ResearchMaintainsOutperform$103 $90.00
2026-05-08CitizensMaintainsMarket Outperform$113 $98.00
2026-02-20Barrington ResearchMaintainsOutperform$103
2026-01-05Barrington ResearchMaintainsOutperform$103
2025-11-24JP MorganMaintainsOverweight$110 $100

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-09-11

  • RSI (14): RSI is 53 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 2.4% above the 50-day MA ($76.58).
  • Price vs 200-day MA: Trading 4.9% above the 200-day MA ($74.78).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-0.24) — short-term momentum is fading.
  • 52-week range: Price sits between the 52-week low ($58.22) and high ($90.82).

USPH Price Chart

Loading chart for USPH

Fundamentals

Revenue (TTM)$1.0B
EBITDA$0M
Free cash flow$0M
Operating cash flow$0M
Book value / share$30.06
Net Debt / EBITDA3.5
WACC12.0%
Revenue growth8.00%
Earnings growth-56.00%

About U.S. Physical Therapy, Inc.

U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.

More in Medical Care Facilities

Screen USPH against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.